Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: Experience of the REMAGUS 02 phase II trial

Autor: Valet, F., de Cremoux, P., Spyratos, F., Servant, N., Dujaric, M.E., Gentien, D., Lehmann-Che, J., Scott, V., Sigal-Zafrani, B., Mathieu, M.C., Bertheau, P., Guinebretière, J.M., Pierga, J.Y., Delaloge, S., Giacchetti, S., Brain, E., Tembo, O., Marty, M., Asselain, B.

Publikováno v: In The Breast December 2013 22(6):1052-1059

Prognostic value of uPA and p53 accumulation measured by quantitative biochemical assays in 1245 primary breast cancer patients: a multicentre study.

Autor: Broët, P, Spyratos, F, Romain, S, Quillien, V, Daver, A, Ricolleau, G, Rallet, A, Toulas, C, Asselain, B

Publikováno v: British Journal of Cancer. 5/1/99, Vol. 80 Issue 3/4, p536. 10p.

Validation of tumour-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumours: a multicentric 2004 national PHRC study

Autor: Jézéquel, P., Campion, L., Spyratos, F., Loussouam, D., Campone, M., Guérin-Charbonnel, C., Joalland, M.P., André, J., Descotes, F., Grenot, C., Roy, Pascal, Carlioz, A., Martin, P.M., Chassevent, A., Jourdan, M-L., Ricolleau, G.

Publikováno v: International Journal of Cancer
International Journal of Cancer, 2011,--, pp.1-12
International Journal of Cancer, Wiley, 2011,--, pp.1-12

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::85f9cc49721270bb3263d73b3b9fa58b
https://hal.science/hal-00697967

Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

Autor: Look M, van Putten W, Duffy M, Harbeck N, Ij, Christensen, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Cg, Fred Sweep, Ulm K, Jp, Peyrat, Pm, Martin, Magdelenat H, Brünner N, Catherine Duggan, Bw, Lisboa, Po, Bendahl, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder M, Manders P, Edward Fiets W, Blankenstein M, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex L, Klijn J, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens J, Po, Bendah

Publikováno v: Thrombosis and Haemostasis, 90, 538-48
Thrombosis and Haemostasis, 90, 538-548. Georg Thieme Verlag
Europe PubMed Central
Thrombosis and Haemostasis, 90, 3, pp. 538-48
Scopus-Elsevier

Item does not contain fulltext In this report we present an extension of the pooled analysis of the prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I in breast cancer patients. We analyzed a different endpoint, m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c930058ef1b9e1daab6d7e59894e29
https://doi.org/10.1160/th02-11-0264

[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer : multicentric retrospective study I. DNA synthesis enzyme activities]

Autor: Spyratos F, Romain S, Rostaing-Puissant B, Daver A, Collona M, Descotes F, Pm, Martin, Philippe Bougnoux, Roth H, Bolla M

Publikováno v: Europe PubMed Central

As part of a clinical research project co-ordinated in Grenoble, six French institutions (CRLCC Angers, CHU Grenoble, Hospices civils Lyon, AP Marseille, CRLCC St-Cloud, CHU Tours) grouped together in order to study the following proliferative parame

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4792bb62295d1f097f91915d38d54171
https://pubmed.ncbi.nlm.nih.gov/10477385